Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizhu Lin

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Human Molecular Genetics|July 28, 2022
ETS1 loss in mice impairs cardiac outflow tract septation via a cell migration defect autonomous to the neural crestLizhu Lin, Antonella Pinto, Lu Wang, et al.
Translational Lung Cancer Research|January 13, 2023
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort studyZhiwei Xiao, Lingling Sun, Yating Zheng, et al.
Heliyon|January 23, 2025
A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagyJue Zhang, Zhipeng Qu, Xi Xiao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 22, 2026
Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axisYi Yuan, Ruisheng Zhou, Zengjie Ye, et al.
The Lancet. Oncology|September 15, 2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trialsWenfeng Fang, Yunpeng Yang, Yuxiang Ma, et al.
Nature Genetics|September 4, 2007
Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2Wenlai Zhou, Lizhu Lin, Arindam Majumdar, et al.
JAMA Oncology|February 26, 2026
First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical TrialYunpeng Yang, Chia-Jui Yen, Jianji Pan, et al.
BMC Cancer|March 24, 2018
The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissuesNong Yang, Yi Li, Zhidong Liu, et al.
Cell Stem Cell|March 29, 2008
The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathwayYibing Qyang, Silvia Martin-Puig, Murali Chiravuri, et al.
Imeta|June 20, 2024
GutUDB: A comprehensive multiomics database for intestinal diseasesYi Bao, Yaxin Chen, Lizhu Lin, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Human Molecular Genetics|July 28, 2022
ETS1 loss in mice impairs cardiac outflow tract septation via a cell migration defect autonomous to the neural crestLizhu Lin, Antonella Pinto, Lu Wang, et al.
Translational Lung Cancer Research|January 13, 2023
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort studyZhiwei Xiao, Lingling Sun, Yating Zheng, et al.
Heliyon|January 23, 2025
A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagyJue Zhang, Zhipeng Qu, Xi Xiao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 22, 2026
Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axisYi Yuan, Ruisheng Zhou, Zengjie Ye, et al.
The Lancet. Oncology|September 15, 2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trialsWenfeng Fang, Yunpeng Yang, Yuxiang Ma, et al.
Nature Genetics|September 4, 2007
Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2Wenlai Zhou, Lizhu Lin, Arindam Majumdar, et al.
JAMA Oncology|February 26, 2026
First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical TrialYunpeng Yang, Chia-Jui Yen, Jianji Pan, et al.
BMC Cancer|March 24, 2018
The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissuesNong Yang, Yi Li, Zhidong Liu, et al.
Cell Stem Cell|March 29, 2008
The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathwayYibing Qyang, Silvia Martin-Puig, Murali Chiravuri, et al.
Imeta|June 20, 2024
GutUDB: A comprehensive multiomics database for intestinal diseasesYi Bao, Yaxin Chen, Lizhu Lin, et al.
Pageof 15